With 9.94 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.41 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $57.2 whereas the lowest price it dropped to was $56.46. The 52-week range on CVS shows that it touched its highest point at $83.25 and its lowest point at $52.77 during that stretch. It currently has a 1-year price target of $67.59. With its current market cap of 71.43 billion, CVS has annualized dividend of $2.66 while the current yield stands at 4.68%. CVS paid its most recent dividend on 1729468800, while the ex-dividend date for that was 1729468800. Beta for the stock currently stands at 0.53.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CVS was down-trending over the past week, with a drop of -12.67%, but this was down by -2.24% over a month. Three-month performance dropped to -3.19% while six-month performance fell -16.22%. The stock lost -17.70% in the past year, while it has lost -28.09% so far this year. A look at the trailing 12-month EPS for CVS yields 5.62 with Next year EPS estimates of 7.20. For the next quarter, that number is 1.55. This implies an EPS growth rate of -25.82% for this year and 11.12% for next year.
Float and Shares Shorts:
At present, 1.29 billion CVS shares are outstanding with a float of 1.26 billion shares on hand for trading. On 2024-09-30, short shares totaled 19.75 million, which was 157.00001 higher than short shares on 1724976000. In addition to Mr. Vijay Patel as the firm’s Senior Director of Business Development & CVS Health and Partner & Co-Founder, Mr. James David Clark serves as its Senior VP, Controller & Chief Accounting Officer.
Institutional Ownership:
Through their ownership of 0.83044 of CVS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, CVS reported revenue of $91234000000.0 and operating income of $3045000000.0. The EBITDA in the recently reported quarter was $4220000000.0 and diluted EPS was $1.41.
